Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
GRAIL, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
GRAL
Nasdaq
2836
grail.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for GRAIL, Inc.
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Mar 2nd, 2026 2:01 pm
Here’s What Analysts Are Saying About Grail Inc. (GRAL)
- Feb 26th, 2026 10:19 pm
GRAIL to Present at the TD Cowen 46th Annual Health Care Conference
- Feb 24th, 2026 2:02 pm
GRAIL (GRAL) Valuation Reassessed After NHS Galleri Trial Setback And Market Selloff
- Feb 23rd, 2026 1:11 pm
Grail Shares Crashes 50% After Major Cancer Screening Trial Fails Main Goal
- Feb 20th, 2026 3:01 pm
Stock Market Today: Nasdaq Charges Higher As Trump Announces Global Tariff; Nvidia Shares Rise (Live Coverage)
- Feb 20th, 2026 2:28 pm
Top Midday Stories: Supreme Court Strikes Down Trump Tariffs; Blue Owl Sells $1.4 Billion of Loan Assets From 3 Funds
- Feb 20th, 2026 9:53 am
Wall Street Set to Open Lower Friday; GDP Growth Slows
- Feb 20th, 2026 7:26 am
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday as Investors Digest Key Economic Data, Geopolitical Tensions
- Feb 20th, 2026 7:15 am
GRAIL, Inc. Q4 2025 Earnings Call Summary
- Feb 20th, 2026 6:30 am
GRAIL Inc (GRAL) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic Challenges
- Feb 19th, 2026 10:00 pm
GRAIL Q4 Earnings Call Highlights
- Feb 19th, 2026 7:10 pm
Biotech Grail shares plunge after key trial fails to meet primary endpoint
- Feb 19th, 2026 3:06 pm
GRAIL Reports Fourth Quarter and Full Year 2025 Financial Results
- Feb 19th, 2026 2:02 pm
Landmark NHS-Galleri Trial Demonstrates a Substantial Reduction in Stage IV Cancer Diagnoses, Increased Stage I and II Detection of Deadly Cancers, and Four-Fold Higher Cancer Detection Rate
- Feb 19th, 2026 2:01 pm
Here Are Thursday’s Top Wall Street Analyst Research Calls: Analog Devices, Chewy, Credo Technology, eBay, Fiverr, Shopify, Verizon, and More
- Feb 19th, 2026 6:09 am
GRAIL to Announce Fourth Quarter and Full Year 2025 Financial Results
- Feb 16th, 2026 7:00 am
Is It Too Late To Consider GRAIL (GRAL) After A 186% One Year Surge?
- Feb 5th, 2026 6:25 pm
How The GRAIL (GRAL) Story Is Shifting With Galleri And New Valuation Clues
- Feb 5th, 2026 3:10 pm
Hims & Hers Scores A Cancer Deal With Grail, But Shares Reverse Lower
- Feb 4th, 2026 2:05 pm
Scroll